Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Expert Rev Clin Immunol. 2011 Jan;7(1):75–91. doi: 10.1586/eci.10.81

Table 2.

Studies combining local application of microbial products with photodynamic therapy of tumors.

Adjuvant Source PDT agent Tumor model Ref.
OK432 Penicillin-killed streptococci Hematoporphyrin derivative Murine NR-S1 squamous cell carcinoma [153]
CpG Oligodeoxynucleotide BPD (verteporfin) Murine 4T1 mammary carcinoma [154]
MCWE Mycobacterium cell
wall extract
Photofrin, BPD, mTHPC, ZnPc Murine EMT6 sarcoma [155]
BCG Live mycobacterial vaccine Photofrin, BPD, mTHPC, ZnPc Murine EMT6 sarcoma [156]
Cryptosporidium
parvum
Killed bacterial vaccine Hematoporphyrin derivative Murine MBT2 transitional cell carcinoma [157]
Glycated chitosan Polysaccharide preparation Photofrin, mTHPC Murine EMT6 sarcoma, line 1
lung cancer
[133]
Schizophyllan Fungal β-glucan Photofrin Murine SCCVII squamous carcinoma [134]
Zymosan Yeast cell wall extract Photofrin, mTHPC Murine SCCVII squamous and LLC
lung carcinomas
[135]
Imiquimod
topical
Small molecule TLR8 agonist ALA–PPIX Human HPV-associated vulval
intraepithelial neoplasia
[158]

ALA–PPIX: 5-aminolevulinic acid–protoporphyrin IX; BCG: Bacillus Calmette–Guérin; BPD: Benzoporphyrin derivative; HPV: Human papilloma virus; LLC: Lewis lung carcinoma; MCWE: Mycobacterium cell wall extract; mTHPC: M-tetrahydroxyphenylchlorin; PDT: Photodynamic therapy; SCC: Squamous cell carcinoma; ZnPc: Zinc phtalocyanine.